AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2004
Jun 7, 2004
35081_dirs_2004-06-07_8505ccfb-b05b-4a78-a9d0-625e1d35d1e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLICKNSETTLE COM INC (clik)
CIK: 0000925741
Period of Report: 2004-06-04
Reporting Person: SPECHT WILLEM F (VP,Director of Info Technology)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-06-04 | Stock Option (Right to Buy) | $0.14 | A | 70000 | Acquired | 2014-06-04 | Common Stock (70000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to buy) | $0.232 | 2012-03-15 | Common Stock (210000) | 210000 | Direct |
| Stock Option (Right to buy) | $2.594 | 2008-05-11 | Common Stock (60000) | 60000 | Direct |
| Stock Option (Right to buy) | $0.5625 | 2007-05-13 | Common Stock (30000) | 30000 | Direct |
| Stock Option (Right to buy) | $0.8125 | 2006-05-11 | Common Stock (16000) | 16000 | Direct |
| Stock Option (Right to buy) | $ | 2005-04-18 | Common Stock (20000) | 20000 | Direct |
| Stock Option (Right to buy) | $0.042 | 2013-03-14 | Common Stock (450000) | 450000 | Direct |
Footnotes
F1: 50% of this options vests and becomes exercisable on 6/4/05 and the remaining 50% vests and becomes exercisable on 6/4/06.
F2: 50% of this option vested and became exercisable on 3/15/03 and the remaining 50% vested and became exercisable on 3/15/04.
F3: This option is divided into five 4,000 tranches at the following exercise prices: $0.815, $0.891, $0.969, $1.047 and $1.125.
F4: 50% of this option vested and became exercisable on 3/14/04 and the remaining 50% vests and becomes exercisable on 3/14/05.
More from BioCardia, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27